story of the week
Rosuvastatin for Patients at Intermediate Risk for Cardiovascular Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cholesterol Lowering in Intermediate-Risk Persons Without Cardiovascular Disease
N. Engl. J. Med 2016 Apr 02;[EPub Ahead of Print], S Yusuf, J Bosch, G Dagenais, J Zhu, D Xavier, L Liu, P Pais, P López-Jaramillo, LA Leiter, A Dans, A Avezum, LS Piegas, A Parkhomenko, K Keltai, M Keltai, K Sliwa, RJ Peters, C Held, I Chazova, K Yusoff, BS Lewis, P Jansky, K Khunti, WD Toff, CM Reid, J Varigos, G Sanchez-Vallejo, R McKelvie, J Pogue, H Jung, P Gao, R Diaz, E LonnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.